Programmed death ligand-1 expression in non-small cell lung cancer-Reference-Cited by-同舟云学术

Programmed death ligand-1 expression in non-small cell lung cancer

Published:2013-11-11 Issue:1 Volume:94 Page:107-116
ISSN:0023-6837
Container-title:Laboratory Investigation
language:en
Short-container-title:Lab Invest

Author:

Velcheti Vamsidhar,Schalper Kurt A,Carvajal Daniel E,Anagnostou Valsamo K,Syrigos Konstantinos N,Sznol Mario,Herbst Roy S,Gettinger Scott N,Chen Lieping,Rimm David L

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Link

http://www.nature.com/articles/labinvest2013130.pdf

Reference24 articles.

1. Detterbeck FC, Boffa DJ, Tanoue LT . The new lung cancer staging system. Chest 2009;136:260–271.

2. Petrelli NJ, Winer EP, Brahmer J et al. Clinical cancer advances 2009: major research advances in cancer treatment, prevention, and screening—a report from the American Society of Clinical Oncology. J Clin Oncol 2009;27:6052–6069.

3. Chen L . Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 2004;4:336–347.

4. Sznol M, Chen L . Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer. Clin Cancer Res 2013;19:1021–1034.

5. Brahmer JR, Tykodi SS, Chow LQ et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. New Eng J Med 2012;366:2455–2465.

Cited by 673 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BCAM (basal cell adhesion molecule) protein expression in different tumor populations;Discover Oncology;2024-08-29

2. Modulation of MHC expression by interferon-gamma and its influence on PBMC-mediated cytotoxicity in canine mast cell tumour cells;Scientific Reports;2024-08-01

3. Low densities of immune cells indicate unfavourable overall survival in patients suffering from squamous cell carcinoma of the lung;Scientific Reports;2024-06-20

4. Prognostic value of body mass index for first-line chemoimmunotherapy combinations in advanced non-small cell lung cancer in Chinese population;Heliyon;2024-06

5. Overview of Molecular Diagnostics in Irish Clinical Oncology;HRB Open Research;2024-03-26